|
|
||||||||
EDITORIAL |
1 From the Pennington Biomedical Research Center, Baton Rouge, LA.
See corresponding article on page 379.
The article by Janssen et al (1) in this issue of the Journal examined whether body mass index (BMI; in kg/m2) adds to the risk associated with waist circumference (WC). The authors made several important points. On the basis of data from the National Health and Nutrition Examination Survey conducted between 1988 and 1994, they showed that the BMI is related to cardiovascular disease (CVD) risk factors in a graded fashionie, as the BMI increases, the CVD risk increases. However, other conditions, such as diabetes, sleep apnea, cancer, and osteoarthritis, were not included in the risks evaluated in their analysis, which limits their overall conclusions about the relation of BMI and WC to CVD risk. Moreover, they showed that most of the information about CVD risks that is obtained from BMI can also be obtained from WC. Finally, Janssen et al showed that, when WC was used as a continuous variable, it accounted for the risk of CVD better than it did when it was dichotomized with the use of the risk algorithm published by the National Institutes of Health (2). These are important findings, and they led me to propose a new way of classifying WC (Table 1
).
|
30 for obesity, which was further divided into grades 1-3, with BMIs of 30-34.9, 35-39.9, and
40, respectively (4).
Janssen et al stated, "It is possible that WC alone could be used as an indicator of health risk and that measures of BMI would not be required." In my judgment, this would be a bad idea. The BMI is composed of weight and height. To propose that clinicians should not obtain these measures is irresponsible, because height and weight are important indicators of health status and are easy for clinical personnel to measure. Janssen et al also stated that "most members of the population cannot readily calculate their BMI." This difficulty is easily remedied, because there are both tables and nomograms from which BMI can be determined. A table that allows anyone to determine his or her BMI easily by using either pounds and inches or kilograms and centimeters is shown in Table 2
. Those interested can be instructed thus: Simply locate your height in inches along the left side or in centimeters along the right side, and then move toward the center along the same line until you come to the cell with the weight closest to your own in either pounds or kilograms. Your BMI is given above and below this cell, in the rows of boldface numbers at the top and bottom of the page.
|
The proposal in Table 1
is an attempt to open a new dialogue on this issue. The mean (± SD) value for WC obtained by using the data from the National Center for Health Statistics (Table 1
in the article by Janssen et al) provides the basis for this proposal. Although the data probably are somewhat skewed, 2 SDs around the mean for the WC of
40 cm (80-120 cm in men and 70-110 cm in women) would include
95% of the population. Very high and very low risks were defined as those above or below the 5th or 95th percentile, respectively. The low and high categories were the lower and higher 2 SDs, respectively. The advantage for the clinician and the public alike of a simple criterion for WC categories is obvious. This criterion is similar to the basis for selecting 25 kg/m2 as the upper limit of normal for BMI and 200 mg/dL as the beginning of the high-risk category of high cholesterol.
Central adiposity is a key criterion of the metabolic syndrome (10). Including the newly proposed categories in the algorithm for defining the metabolic syndrome may improve the usefulness of criteria for evaluating the risk of central obesity.
In summary, nothing in the article by Janssen et al dissuades me from making measurement of the BMI the first evaluation as proposed in the algorithm from the National Heart, Lung, and Blood Institute's evidence report (2), but, at any given BMI, the use of a measure of central adiposity may improve the criteria for assessing risk. For assessing the risk of diabetes, sleep apnea, osteoarthritis, and cancer, there is as yet insufficient evidence to throw out BMI in favor of WC as the first step in the line of assessment.
REFERENCES
Related articles in AJCN:
This article has been cited by other articles:
![]() |
A. Stavropoulos-Kalinoglou, G. S Metsios, Y. Koutedakis, A. M Nevill, K. M Douglas, A. Jamurtas, J. J C S V. van Zanten, M. Labib, and G. D Kitas Redefining overweight and obesity in rheumatoid arthritis patients Ann Rheum Dis, October 1, 2007; 66(10): 1316 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bigaard, B. L Thomsen, A. Tjonneland, and T. I. Sorensen Does waist circumference alone explain obesity-related health risk? Am. J. Clinical Nutrition, September 1, 2004; 80(3): 790 - 791. [Full Text] [PDF] |
||||
![]() |
I. Janssen, P. T Katzmarzyk, and R. Ross Reply to J Bigaard et al Am. J. Clinical Nutrition, September 1, 2004; 80(3): 791 - 792. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |